Alyeska Investment Group, L.P. Aclaris Therapeutics, Inc. Transaction History

Alyeska Investment Group, L.P.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	SELL	$2.13 - $7.06 $950,889 - $3.15 Million	-446,427 Reduced 72.75%	167,208 $0
Q2 2018 Aug 14, 2018	SELL	$16.46 - $20.33 $3.92 Million - $4.84 Million	-238,139 Reduced 27.96%	613,635 $12.3 Million
Q1 2018 May 15, 2018	BUY	$17.08 - $25.64 $3.14 Million - $4.71 Million	183,890 Added 27.53%	851,774 $14.9 Million
Q4 2017 Feb 14, 2018	BUY	$21.47 - $27.8 $4.29 Million - $5.56 Million	200,000 Added 42.75%	667,884 $16.5 Million
Q3 2017 Nov 14, 2017	BUY	$23.02 - $28.8 $10.8 Million - $13.5 Million	467,884	467,884 $12.1 Million

50.7M

30.6K

Ticker ACRS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 66,671,800
Market Cap $255M
Description
Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...

Get notified when there are updates to the investment portfolio of Alyeska Investment Group, L.P., based on Form 13F filings with the SEC.

Stay updated on Alyeska Investment Group, L.P. with notifications on news.